Solid Dosage Form Drug - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757527
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 153
-
According to Ample Market Research, the global market for Solid Dosage Form Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Solid Dosage Form Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Solid Dosage Form Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Retail Pharmacy grew percent.
Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
This report studies and analyses global Solid Dosage Form Drug status and future trends, to help determine the Solid Dosage Form Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Solid Dosage Form Drug, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Solid Dosage Form Drug market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Solid Dosage Form Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Solid Dosage Form Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Solid Dosage Form Drug key consuming regions, consumption value and demand structure
(5) Solid Dosage Form Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Teva
Boehringer Ingelheim
Biogen
Astellas
Market segment by Type, covers
Tablet
Capsules
Other
Market segment by Application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Solid Dosage Form Drug product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Solid Dosage Form Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Solid Dosage Form Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Solid Dosage Form Drug industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Solid Dosage Form Drug Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Solid Dosage Form Drug Definition
1.2 Global Solid Dosage Form Drug Market Size and Forecast
1.3 China Solid Dosage Form Drug Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Solid Dosage Form Drug Market Size: China VS Global Growth Rate, 2018-2029
1.6 Solid Dosage Form Drug Market Dynamics
1.6.1 Solid Dosage Form Drug Market Drivers
1.6.2 Solid Dosage Form Drug Market Restraints
1.6.3 Solid Dosage Form Drug Industry Trends
1.6.4 Solid Dosage Form Drug Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Solid Dosage Form Drug, Global Market Share by Company, 2018-2023
2.2 Global Solid Dosage Form Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Solid Dosage Form Drug Concentration Ratio
2.4 Global Solid Dosage Form Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Solid Dosage Form Drug Major Companies Product Type
2.6 Head Office and Solid Dosage Form Drug Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Solid Dosage Form Drug, China Market Share by Company, 2018-2023
3.2 China Solid Dosage Form Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Solid Dosage Form Drug Industry Chain
4.2 Solid Dosage Form Drug Upstream Analysis
4.2.1 Solid Dosage Form Drug Core Raw Materials
4.2.2 Main Manufacturers of Solid Dosage Form Drug Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Solid Dosage Form Drug Production Mode
4.6 Solid Dosage Form Drug Procurement Model
4.7 Solid Dosage Form Drug Industry Sales Model and Sales Channels
4.7.1 Solid Dosage Form Drug Sales Model
4.7.2 Solid Dosage Form Drug Typical Distributors
5 Sights by Type5.1 Solid Dosage Form Drug Classification
5.1.1 Tablet
5.1.2 Capsules
5.1.3 Other5.2 By Type, Global Solid Dosage Form Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Solid Dosage Form Drug Consumption Value, 2018-2029
6 Sights by Application6.1 Solid Dosage Form Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other6.2 By Application, Global Solid Dosage Form Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Solid Dosage Form Drug Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Solid Dosage Form Drug Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Solid Dosage Form Drug Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Solid Dosage Form Drug & Forecasts, 2018-2029
7.3.2 By Country, North America Solid Dosage Form Drug Market Size Market Share7.4 Europe
7.4.1 Europe Solid Dosage Form Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Solid Dosage Form Drug Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Solid Dosage Form Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Solid Dosage Form Drug Market Size Market Share7.6 South America
7.6.1 South America Solid Dosage Form Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Solid Dosage Form Drug Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Solid Dosage Form Drug Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Solid Dosage Form Drug Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Solid Dosage Form Drug Market Size, 2018-2029
8.3.2 By Type, U.S. Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Solid Dosage Form Drug Market Size, 2018-2029
8.4.2 By Type, Europe Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Solid Dosage Form Drug Market Size, 2018-2029
8.5.2 By Type, China Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Solid Dosage Form Drug Market Size, 2018-2029
8.6.2 By Type, Japan Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Solid Dosage Form Drug Market Size, 2018-2029
8.7.2 By Type, South Korea Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Solid Dosage Form Drug Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Solid Dosage Form Drug Market Size, 2018-2029
8.9.2 By Type, India Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Solid Dosage Form Drug Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Solid Dosage Form Drug Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Johnson & Johnson
9.1.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.1.2 Johnson & Johnson Company Profile and Main Business
9.1.3 Johnson & Johnson Solid Dosage Form Drug Models, Specifications and Application
9.1.4 Johnson & Johnson Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.1.5 Johnson & Johnson Recent Developments9.2 Novartis
9.2.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.2.2 Novartis Company Profile and Main Business
9.2.3 Novartis Solid Dosage Form Drug Models, Specifications and Application
9.2.4 Novartis Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.2.5 Novartis Recent Developments9.3 Roche
9.3.1 Roche Company Information, Head Office, Market Area and Industry Position
9.3.2 Roche Company Profile and Main Business
9.3.3 Roche Solid Dosage Form Drug Models, Specifications and Application
9.3.4 Roche Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.3.5 Roche Recent Developments9.4 AbbVie
9.4.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.4.2 AbbVie Company Profile and Main Business
9.4.3 AbbVie Solid Dosage Form Drug Models, Specifications and Application
9.4.4 AbbVie Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.4.5 AbbVie Recent Developments9.5 Merck & Co.
9.5.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position
9.5.2 Merck & Co. Company Profile and Main Business
9.5.3 Merck & Co. Solid Dosage Form Drug Models, Specifications and Application
9.5.4 Merck & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.5.5 Merck & Co. Recent Developments9.6 Bristol Myers Squibb
9.6.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
9.6.2 Bristol Myers Squibb Company Profile and Main Business
9.6.3 Bristol Myers Squibb Solid Dosage Form Drug Models, Specifications and Application
9.6.4 Bristol Myers Squibb Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.6.5 Bristol Myers Squibb Recent Developments
9.7 GlaxoSmithKline
9.7.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
9.7.2 GlaxoSmithKline Company Profile and Main Business
9.7.3 GlaxoSmithKline Solid Dosage Form Drug Models, Specifications and Application
9.7.4 GlaxoSmithKline Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.7.5 GlaxoSmithKline Recent Developments
9.8 Pfizer
9.8.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.8.2 Pfizer Company Profile and Main Business
9.8.3 Pfizer Solid Dosage Form Drug Models, Specifications and Application
9.8.4 Pfizer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.8.5 Pfizer Recent Developments
9.9 Sanofi
9.9.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.9.2 Sanofi Company Profile and Main Business
9.9.3 Sanofi Solid Dosage Form Drug Models, Specifications and Application
9.9.4 Sanofi Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.9.5 Sanofi Recent Developments9.10 Takeda
9.10.1 Takeda Company Information, Head Office, Market Area and Industry Position
9.10.2 Takeda Company Profile and Main Business
9.10.3 Takeda Solid Dosage Form Drug Models, Specifications and Application
9.10.4 Takeda Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.10.5 Takeda Recent Developments
9.11 AstraZeneca
9.11.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
9.11.2 AstraZeneca Company Profile and Main Business
9.11.3 AstraZeneca Solid Dosage Form Drug Models, Specifications and Application
9.11.4 AstraZeneca Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.11.5 AstraZeneca Recent Developments
9.12 Bayer
9.12.1 Bayer Company Information, Head Office, Market Area and Industry Position
9.12.2 Bayer Company Profile and Main Business
9.12.3 Bayer Solid Dosage Form Drug Models, Specifications and Application
9.12.4 Bayer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.12.5 Bayer Recent Developments
9.13 Eli Lilly & Co.
9.13.1 Eli Lilly & Co. Company Information, Head Office, Market Area and Industry Position
9.13.2 Eli Lilly & Co. Company Profile and Main Business
9.13.3 Eli Lilly & Co. Solid Dosage Form Drug Models, Specifications and Application
9.13.4 Eli Lilly & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.13.5 Eli Lilly & Co. Recent Developments
9.14 Gilead Sciences
9.14.1 Gilead Sciences Company Information, Head Office, Market Area and Industry Position
9.14.2 Gilead Sciences Company Profile and Main Business
9.14.3 Gilead Sciences Solid Dosage Form Drug Models, Specifications and Application
9.14.4 Gilead Sciences Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.14.5 Gilead Sciences Recent Developments
9.15 Amgen
9.15.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.15.2 Amgen Company Profile and Main Business
9.15.3 Amgen Solid Dosage Form Drug Models, Specifications and Application
9.15.4 Amgen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.15.5 Amgen Recent Developments
9.16 Teva
9.16.1 Teva Company Information, Head Office, Market Area and Industry Position
9.16.2 Teva Company Profile and Main Business
9.16.3 Teva Solid Dosage Form Drug Models, Specifications and Application
9.16.4 Teva Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.16.5 Teva Recent Developments
9.17 Boehringer Ingelheim
9.17.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
9.17.2 Boehringer Ingelheim Company Profile and Main Business
9.17.3 Boehringer Ingelheim Solid Dosage Form Drug Models, Specifications and Application
9.17.4 Boehringer Ingelheim Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.17.5 Boehringer Ingelheim Recent Developments
9.18 Biogen
9.18.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.18.2 Biogen Company Profile and Main Business
9.18.3 Biogen Solid Dosage Form Drug Models, Specifications and Application
9.18.4 Biogen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.18.5 Biogen Recent Developments
9.19 Astellas
9.19.1 Astellas Company Information, Head Office, Market Area and Industry Position
9.19.2 Astellas Company Profile and Main Business
9.19.3 Astellas Solid Dosage Form Drug Models, Specifications and Application
9.19.4 Astellas Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.19.5 Astellas Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Solid Dosage Form Drug Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Solid Dosage Form Drug Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Solid Dosage Form Drug Global and China Top Players has a wide range of applications, including
The Solid Dosage Form Drug Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Solid Dosage Form Drug Global and China Top Players Market across the extensive corporate landscape.
The Solid Dosage Form Drug Global and China Top Players Market is expected to reach a considerable market valuation.
